Astellas Plots US Portfolio Expansion

 
• By Jessica Merrill

US president Mark Reisenauer talked to Scrip about the company's next growth drivers, including fezolinetant for vasomotor symptoms and zolbetuximab for gastric cancer.

chart a course
Astellas is charting a course for growth • Source: Shutterstock

More from Strategy

More from Business